Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pan-Ultrashort Regimen for Drug-susceptible and Drug-resistant Pulmonary Tuberculosis: A Multi-Center Randomized Controlled Trial

NCT06905522 is registered in ClinicalTrials.gov with Shenzhen Third People's Hospital as lead sponsor.

NCT NCT06905522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06905522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pan-Ultrashort Regimen for Drug-susceptible and Drug-resistant Pulmonary Tuberculosis: A Multi-Center Randomized Controlled Trial
Lead sponsor
Shenzhen Third People's Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
June 18, 2025
Completion date
December 31, 2029
Enrollment
610 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis